Drug of Abuse Testing

Drug of Abuse Testing Market Predicted to Reach US$ 10.7 billion by 2030 According to Precedence Research, the global drug of abuse testing market size was valued at US$ 5.8 billion in 2020.

Share This Article

The drug of abuse testing market is predicted to record a growth rate of 6.4% from 2021-2030 and is projected to reach US$ 10.7 billion by 2030.

The study provides the overall revenue of the global drug of abuse testing market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global drug of abuse testing market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the drug of abuse testing industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1313

Crucial factors accountable for market growth are:

  • Growing usage of drugs like marijuana, cocaine among the youth
  • Growing cases of drug use disorder
  • Rising number deaths related to drug overdose
  • Government initiatives to tackle drug abuse
  • Technological advancements and development of cost-effective test kits
  • Rising prevalence of HIV among the drug injectors

Report Highlights

  • By drug type, the marijuana/cannabis segment led the global drug of abuse market with remarkable revenue share in 2020. This is attributed to the increased consumption and popularity of the marijuana. Moreover, in countries like India, it is easily available to the drug users due to the lack of proper administrative control on the illegal drug suppliers.
  • By sample type, the urine segment led the global drug of abuse market with remarkable revenue share in 2020. This is because the urinalysis is the most accurate and feasible test. Kidney helps to remove wastes and other toxic materials from the blood through urine and hence urinalysis is much more effective.
  • By end user, the workplaces segment led the global drug of abuse market with remarkable revenue share in 2020. The employers need to know about the health of their employ. A drug user frequently switches job and highly unproductive and inefficient in his work. Hence, the workplaces need to conduct drug of abuse tests.

Scope of the Drug of Abuse Market Report

Report Coverage Details
Market Size US$ 10.7 Billion by 2030
Growth Rate From 2021 to 2030 CAGR of 6.4%
Fastest Growing Market Asia Pacific
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Drug Type, Sample Type, End User, Region

Regional Snapshots

North America dominated the global drug of abuse testing market. This is attributed to the highest consumption of drugs such as heroin, cocaine, cannabis, and alcohol in the region. Moreover government initiatives like the implementation Patients and Communities Act to counter the problem of drug abuse is a major factor influencing the growth of the market across the region. According to the National Survey on Drug Use and Health Report, over 500,000 teenagers in US were suffering from drug use disorders in 2018. Hence the rising use of drugs among the teenagers is a major threat to the national interests that propels the growth of the drug of abuse testing market.Further, the presence of numerous key market players in the region and their strategical developments fueled the growth of the drug of abuse market in this region.

Asia Pacific is expected to be the fastest-growing region. According to the Australian National Council – Asia Pacific Report, Cambodia has become the leading source of cannabis the globe. Major economy like China has taken an initiative to set up a huge network of drug treatment centers across the nation. Around 74.4% of the Hong Kong drug users prefers heroin and around 80% of the HIV cases in Indonesia is directly associated with the injection drug use. The Asia Pacific is becoming a major market for the illicit drug traders due to the failure of government to tackle this situation. Therefore, Asia Pacific has a huge growth potential for the drug of abuse testing market.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global drug of abuse testing market are as follows:

  • Danaher Corporation
  • LabCorp
  • Abbott Laboratories
  • Quest Diagnostics, Inc.
  • Cordant Health Solutions
  • DrugScan
  • Legacy Medical Services
  • Mayo Clinic Laboratories
  • LGC Group
  • Precision Diagnostics

Market Segmentation

By Drug Type

  • Alcohol
  • Cocaine
  • Marijuana/Cannabis
  • LSD
  • Opioids
  • Others

By Sample Type

  • Urine
  • Saliva
  • Blood
  • Others

By End User

  • Workplaces
  • Criminal Justice Systems
  • Hospitals
  • Research Labs

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the drug of abuse testing market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Why should you invest in this report?

If you are aiming to enter the global drug of abuse testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for drug of abuse testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Drug of Abuse Testing Market, By Drug

7.1. Drug of Abuse Testing Market, by Drug Type, 2021-2030

7.1.1. Alcohol

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Cocaine

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Marijuana/Cannabis

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. LSD

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Opioids

7.1.5.1. Market Revenue and Forecast (2019-2030)

7.1.6. Others

7.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Drug of Abuse Testing Market, By End User

8.1. Drug of Abuse Testing Market, by End User, 2021-2030

8.1.1. Workplaces

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Criminal Justice Systems

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hospitals

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Research Labs

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Drug of Abuse Testing Market, By Sample 

9.1. Drug of Abuse Testing Market, by Sample, 2021-2030

9.1.1. Urine

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Saliva

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Blood

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Drug of Abuse Testing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Sample (2019-2030)

Chapter 11. Company Profiles

11.1. Danaher Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. LabCorp

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Abbott Laboratories

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Quest Diagnostics, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cordant Health Solutions

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. DrugScan

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Legacy Medical Services

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Mayo Clinic Laboratories

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. LGC Group

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Precision Diagnostics

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1313

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →